Frequent nosebleeds, prolonged dental bleeding, heavy periods, and bruises that appear out of proportion to an injury can point to von Willebrand disease. The pattern over a lifetime matters more than any single bruise or normal screening test.
- Bleeding pattern matters most: recurrent mucosal bleeding, heavy menstrual bleeding, and procedure-related bleeding are more suggestive than an occasional bruise.
- ISTH Bleeding Assessment Tool scores of 4 or more in adult men, 6 or more in adult women, and 3 or more in children support formal testing.
- VWF antigen below 30 IU/dL confirms type 1 von Willebrand disease in the appropriate clinical setting; 30-50 IU/dL with abnormal bleeding can still support diagnosis.
- Normal PT and aPTT do not exclude von Willebrand disease because many affected people have normal routine clotting-screen results.
- Core confirmatory tests are VWF antigen, platelet-dependent VWF activity, and factor VIII activity, usually repeated when the patient is well.
- Heavy menstrual bleeding with ferritin below 15 micrograms/L strongly supports depleted iron stores and deserves parallel iron assessment.
- Type 2B VWD can cause a low platelet count, while type 3 disease often produces extremely low VWF and factor VIII levels.
- Emergency symptoms include uncontrolled bleeding, fainting, black stool, coughing blood, severe headache after head trauma, or soaking a pad or tampon hourly for 2 hours.
Which bleeding pattern raises suspicion for VWD?
Von Willebrand disease symptoms usually involve skin and mucous membranes rather than deep muscle or joint bleeding. The more characteristic pattern is recurrent nosebleeds, gum bleeding, heavy periods, easy bruising, and prolonged bleeding after dental work, childbirth, surgery, or a cut.
A single shin bruise after moving furniture is common. Repeated bruises larger than 5 cm without a remembered impact, nosebleeds lasting over 10 minutes, or bleeding that restarts after seeming to stop deserve a different level of attention. In my clinic, the clue is often not severity at one event but the same story appearing at school, the dentist, childbirth, and minor procedures.
Mucocutaneous bleeding means bleeding from surfaces rich in tiny vessels: nose, gums, skin, menstrual lining, and the gastrointestinal tract. VWD impairs the first platelet plug, so it usually causes this surface-type bleeding; repeated spontaneous joint bleeds instead point clinicians more toward severe haemophilia or another coagulation-factor disorder.
Dr. Thomas Klein has found that patients often normalize a family pattern: “everyone in our family has heavy periods” or “we all bleed at the dentist.” A parent, sibling, or child with similar symptoms is clinically meaningful because most types of VWD are inherited. Review the practical distinction between ordinary bruising and a coagulation concern in our coagulation panel guide.
Easy bruising versus a possible bleeding disorder
Easy bruising alone rarely proves a bleeding disorder, but bruising combined with mucosal or procedure-related bleeding warrants evaluation. Bruises from VWD are usually recurrent, disproportionate to minor trauma, and accompanied by another bleeding-domain symptom.
Clinicians become more concerned when bruises are spontaneous, unusually large, clustered on the trunk, or paired with gum bleeding, nosebleeds, or heavy periods. Bruising that begins abruptly in adulthood also changes the differential: medications, liver disease, low platelets, nutritional deficiency, and acquired VWD need consideration rather than assuming a lifelong inherited condition.
Platelet count below 150 × 10^9/L suggests thrombocytopenia, not typical type 1 VWD, although type 2B VWD can lower platelets by pulling them out of circulation. A normal platelet count does not prove platelet function is normal. Laboratory artefact can also matter; EDTA-related clumping can create a false low count, as explained in our platelet clumping article.
A 34-year-old teacher I saw had been told her bruising was “just sensitive skin.” Her meaningful history was actually two 25-minute nosebleeds each month, iron treatment twice, and prolonged bleeding after wisdom-tooth removal. That combination has far more diagnostic weight than the appearance of the bruises themselves.
When heavy periods suggest a bleeding disorder
Heavy menstrual bleeding may be the only obvious symptom of VWD, especially in adolescents and younger adults. Soaking a pad or tampon every hour for more than 2 consecutive hours, passing clots larger than 2.5 cm, or bleeding beyond 7 days should prompt a medical review.
A pictorial blood-loss assessment chart score above 100 correlates reasonably with menstrual loss above 80 mL, although real-world chart scoring is imperfect. What I ask instead is practical: Are you changing protection overnight? Do you avoid leaving home on days 1 and 2? Have you ever bled through clothes despite layered protection? Those answers often reveal a problem missed by the word “heavy.”
Ferritin below 15 micrograms/L indicates absent or near-absent iron stores in most otherwise healthy adults. Many clinicians investigate or treat symptomatic menstrual iron deficiency below 30 micrograms/L, particularly when transferrin saturation is below 20%. Heavy periods can therefore produce fatigue, breathlessness, palpitations, and restless legs long before haemoglobin falls; see our guide to low ferritin symptoms.
The 2021 ASH, ISTH, NHF, and WFH management guideline recommends tranexamic acid or hormonal therapy over desmopressin alone for many people with VWD and heavy menstrual bleeding, while choices still depend on pregnancy plans, thrombosis history, and VWD subtype (James et al., 2021). A gynaecology assessment remains necessary because fibroids, adenomyosis, pregnancy complications, and endocrine causes can coexist.
Nosebleeds, gum bleeding, and dental bleeding clues
Recurrent nosebleeds lasting longer than 10 minutes, spontaneous gum bleeding, or dental bleeding that continues for hours are classic VWD clues. Bleeding from a single irritated gumline or during a viral cold is much less specific.
The history becomes compelling when pressure, local treatment, or a routine dental dressing did not control the bleeding as expected. In a healthy person, a small dental extraction site generally settles with local measures; recurrent return visits, delayed oozing the next day, or prior use of antifibrinolytic treatment should be documented before another procedure.
Epistaxis occurring more than five times per year or requiring medical attention is clinically more relevant than an occasional brief nosebleed. Dry air, nasal steroid sprays, and picking can explain nosebleeds, but they do not explain prolonged dental bleeding or heavy menstrual loss at the same time.
Before a planned extraction, bring prior laboratory reports and write down the exact procedure that caused trouble. This improves the referral more than saying “I bleed easily.” For broader preparation advice, our platelet count before tooth extraction guide clarifies why count and function are separate questions.
Initial clotting tests and why normal results can mislead
A full blood count, PT/INR, and aPTT are useful first tests, but normal results do not rule out VWD. PT is usually normal in VWD, and aPTT can remain normal when factor VIII is only mildly reduced or normal.
PT is commonly about 11-14 seconds and INR about 0.8-1.2 in people not taking anticoagulants, although every laboratory sets its own interval. These values assess the extrinsic and common clotting pathways; they do not measure VWF quantity or platelet-dependent VWF function. An isolated normal INR is therefore not reassuring when the bleeding history is strong.
aPTT is often roughly 25-35 seconds, yet many people with type 1 or type 2 VWD have a normal aPTT. It lengthens mainly when factor VIII becomes sufficiently low, which is more likely in type 3 disease or type 2N VWD. The 2021 diagnostic guideline specifically recommends VWD-specific testing rather than using normal screening assays to dismiss a compatible history (Connell et al., 2021).
Kantesti is an AI blood test analyzer that can organize CBC, PT, INR, aPTT, ferritin, and iron findings into a follow-up discussion, but it cannot diagnose VWD from routine screening tests alone. Our aPTT reference guide explains what this assay measures and what it misses.
The von Willebrand disease test panel that confirms diagnosis
The initial VWD diagnostic panel includes VWF antigen, platelet-dependent VWF activity, and factor VIII activity. A result below 30 IU/dL supports type 1 VWD regardless of bleeding history, while 30-50 IU/dL requires a compatible bleeding history and expert interpretation.
VWF antigen measures how much VWF protein is present, while VWF activity measures how well it binds platelets. Modern activity testing often uses GPIbM or GPIbR methods; older ristocetin cofactor assays are more variable, especially at low values. A low activity-to-antigen ratio, often below 0.7, raises suspicion for qualitative type 2 VWD rather than simple type 1 deficiency.
Factor VIII activity below 50 IU/dL can occur in VWD because VWF protects factor VIII from rapid clearance. Very low factor VIII may suggest type 3 VWD or type 2N VWD, but it can also overlap with mild haemophilia A. This is one reason a haematologist may add VWF multimer analysis, collagen-binding studies, targeted genetic testing, or specialised platelet-binding assays.
Kantesti is an AI blood test interpretation platform that flags when a reported VWF antigen, VWF activity, and factor VIII pattern does not align cleanly, helping users prepare focused questions for their clinician. Compare individual test naming conventions in our blood biomarkers guide.
Why VWF results can change and need repeating
VWF is an acute-phase reactant, so stress, exercise, infection, pregnancy, estrogen exposure, and inflammation can temporarily raise the level and obscure mild VWD. Testing should ideally occur when the person is at their usual health baseline rather than during active bleeding, severe illness, or immediately after trauma.
VWF levels can rise twofold or more during physiological stress, which is why an emergency-department sample after a major bleed may look reassuring. Pregnancy commonly raises VWF substantially by the third trimester, then levels can fall quickly after delivery; postpartum bleeding risk must therefore be planned around the person's baseline and late-pregnancy values.
People with blood group O have VWF levels about 25% lower on average than people with non-O blood groups. Blood group affects the reference distribution, but it should not be used to dismiss clinically important bleeding or to deny a diagnosis when formal criteria are met. The 2021 diagnostic guideline advises using local laboratory reference ranges rather than arbitrary blood-group-adjusted cutoffs (Connell et al., 2021).
I usually ask patients to record recent infection, vigorous exercise within 24 hours, pregnancy status, estrogen-containing treatment, and major anxiety around the draw. These details help the laboratory specialist decide whether a normal result is genuinely reassuring. Keep serial laboratory context together with our blood test timeline guide.
How VWD type changes symptoms and laboratory findings
Type 1 VWD is a partial quantitative deficiency, type 2 VWD is a functional defect, and type 3 VWD is near-complete deficiency. The type affects bleeding risk, test patterns, pregnancy planning, and which treatments are safe.
Type 1 accounts for most diagnosed VWD and usually produces mild-to-moderate mucosal bleeding. VWF antigen and activity tend to fall in parallel. Symptoms can still be significant: a modest laboratory reduction in a person with recurrent surgical bleeding matters more than a number interpreted without their history.
Type 2A, 2B, 2M, and 2N are functional subtypes with different assay signatures. Type 2B may cause intermittent thrombocytopenia, while type 2N reduces factor VIII binding and can resemble haemophilia A. Multimer testing is not a routine first-line screen, but it becomes valuable when activity is disproportionately lower than antigen.
Type 3 VWD usually produces VWF levels close to undetectable and may cause severe bleeding, including joint bleeds. Desmopressin is generally ineffective in type 3 disease and can be problematic in type 2B. This is exactly why a subtype label is not academic—it changes the treatment plan.
How clinicians use bleeding scores and family history
A structured bleeding assessment tool turns a vague history into a reproducible clinical score. The ISTH Bleeding Assessment Tool supports testing when scores reach 4 in adult men, 6 in adult women, or 3 in children.
The score asks about 14 domains, including nosebleeds, bruising, oral bleeding, surgery, childbirth, muscle haematomas, and central nervous system bleeding. It credits interventions too: needing iron treatment, nasal packing, cautery, transfusion, or re-operation is more informative than merely saying bleeding was “bad.”
A first-degree relative with laboratory-confirmed VWD increases the pre-test probability substantially. Yet family history can be falsely negative because relatives may never have had surgery, may use hormonal therapy that controls periods, or may have been told their bleeding was normal. Children may not show the pattern until tooth loss, tonsil surgery, or menstruation.
Kantesti's AI-powered blood test analysis tool helps people preserve laboratory trends and family-context notes across appointments; that record can make a haematology referral much more efficient. Our family lab history tracker outlines practical details worth saving.
Medicines and supplements that can worsen bleeding
Aspirin and many non-steroidal anti-inflammatory drugs can worsen VWD bleeding by reducing platelet function. Anticoagulants, antiplatelet medicines, some antidepressants, alcohol excess, and supplements can add to an existing bleeding tendency.
Aspirin permanently affects exposed platelets for their 7-10-day lifespan, while ibuprofen has a shorter reversible effect. Do not stop prescribed aspirin, anticoagulants, or antiplatelet treatment on your own—heart and stroke risks may outweigh bleeding concerns—but do tell the prescriber about suspected VWD before surgery or an invasive procedure.
Selective serotonin reuptake inhibitors can modestly increase mucosal bleeding risk because platelets use serotonin during aggregation. Fish oil, garlic, ginkgo, high-dose vitamin E, and turmeric supplements are often blamed, but the evidence and effect size are variable; the more important practical issue is documenting every product before an operation.
Liver impairment can also prolong clotting tests and reduce platelet production, creating a different bleeding mechanism from VWD. If PT, INR, albumin, bilirubin, or platelet counts are abnormal, clinicians should broaden the work-up; our liver test overview explains these connected markers.
Pregnancy and postpartum bleeding in VWD
Pregnancy often raises VWF and factor VIII, but postpartum levels can fall rapidly and delayed bleeding can occur 1-3 weeks after delivery. Anyone with known or suspected VWD should have a maternity plan shared by obstetrics, anaesthesia, and haematology.
VWF activity and factor VIII are commonly checked in the third trimester, often around 32-36 weeks. A target of at least 50 IU/dL is frequently used for delivery planning, though the precise threshold and preventive treatment depend on subtype, prior bleeding, and local specialist protocol. Levels above that point during pregnancy do not erase a low non-pregnant baseline.
The risk is not limited to delivery-day blood loss. Delayed postpartum haemorrhage may occur after hospital discharge, when VWF naturally declines; prolonged lochia that becomes heavier, dizziness, faintness, or passage of repeatedly large clots needs urgent clinical assessment. This concern is especially relevant if a prior delivery involved retained placenta or late heavy bleeding.
Heavy periods after pregnancy should not be automatically blamed on hormonal adjustment. Check a CBC and ferritin alongside gynaecological review, using our pregnancy ferritin ranges as context for iron follow-up.
What to do before surgery, dental work, or endoscopy
People with confirmed or strongly suspected VWD need a written haemostatic plan before invasive procedures, not simply a normal PT or aPTT. The plan may include desmopressin, tranexamic acid, VWF concentrate, local measures, and post-procedure observation.
Desmopressin releases stored VWF and factor VIII and is often useful in responsive type 1 VWD. A supervised desmopressin trial is preferable before elective surgery because the individual response can vary; fluid restriction and sodium monitoring are relevant because hyponatraemia is a recognised risk, especially in children and older adults.
Tranexamic acid stabilises formed clots and is particularly useful for mouth, nose, and menstrual bleeding. It is often prescribed for several days after dental work, but dosage and suitability must come from the treating team, particularly with kidney impairment, haematuria, or a personal thrombosis history. Never borrow another person's treatment plan.
A procedure letter should list VWD subtype, baseline VWF and factor VIII, prior desmopressin response, allergies, and the specialist contact. The medical advisory board behind Kantesti stresses that laboratory interpretation must support—not replace—this clinician-led planning.
Bleeding symptoms that need urgent medical care
Seek urgent care for bleeding that will not stop with firm pressure, black stools, vomiting blood, fainting, severe weakness, or a significant head injury followed by headache or confusion. These symptoms require assessment regardless of whether VWD has been diagnosed.
Call emergency services for severe bleeding, collapse, chest pain, new neurological symptoms, or rapidly worsening shortness of breath. For menstrual bleeding, soaking through at least one pad or tampon an hour for 2 hours, particularly with dizziness or near-fainting, is a reasonable urgent threshold. Pregnancy and the first 6 weeks after delivery lower the threshold for urgent assessment.
Black tarry stool can indicate upper gastrointestinal bleeding, while bright red rectal bleeding can arise from lower bowel bleeding or haemorrhoids. Neither is safely explained by VWD without an examination, because ulcers, inflammatory bowel disease, polyps, and medication injury may be involved. A normal haemoglobin early in an acute bleed does not reliably exclude substantial blood loss.
Dr. Thomas Klein advises patients not to wait for an outpatient VWF test if active bleeding is escalating. Bring your diagnosis card or prior results if available, but stabilisation comes first. Our blood test for chest pain guide also explains why symptoms, rather than a pending lab result, drive emergency triage.
How to discuss possible VWD results with your clinician
The most useful next step is to pair your exact bleeding history with VWF antigen, VWF activity, factor VIII, CBC, ferritin, and the conditions present at testing. No single borderline VWF result should be read without knowing whether you were ill, pregnant, stressed, or using estrogen.
Ask four direct questions: Which VWF activity assay did this laboratory use? Was I at baseline when sampled? Do antigen and activity suggest a type 2 pattern? Should the tests be repeated or referred to a haemostasis centre? Those questions usually lead to a more productive consultation than asking whether a result is simply “normal.”
As of September 16, 2026, the practical standard remains clinical-context interpretation supported by repeat, subtype-aware testing—not a home screening kit or a single routine coagulation panel. Kantesti AI can help you organise documents in about 60 seconds, while our clinical process follows published methods described in our medical validation approach.
Kantesti serves as an AI lab test interpretation service for people who need plain-language context around laboratory reports, but a haematologist confirms VWD and sets treatment. If you are preparing for an appointment, record dates, bleeding duration, treatments required, and family history; the pattern is often the missing diagnostic test.
Limits of online interpretation and sensible next steps
Online interpretation can identify a pattern worth discussing, but it cannot diagnose VWD, assess active bleeding, or replace a specialist coagulation laboratory. Diagnosis is most reliable when symptoms, repeated VWF testing, subtype studies, and treatment response are considered together.
Some people with VWF values between 30 and 50 IU/dL have clinically important bleeding, while others do not. That uncertainty is real, not a failure of testing. The diagnosis guideline uses the term “low VWF” in some contexts, but clinicians should still address bleeding, iron deficiency, and procedural safety even when labels remain unsettled.
If your screening tests were normal but the story remains persuasive, ask for VWF antigen, platelet-dependent activity, and factor VIII rather than repeatedly checking PT and INR. A specialist may also consider platelet function disorders, connective-tissue conditions, thyroid disease, liver disease, or acquired causes depending on age and accompanying results.
Our AI technology guide describes how Kantesti handles result context and uncertainty. The practical goal is not to self-diagnose from an app; it is to arrive at clinical care with a coherent, date-stamped account of what happened.
Frequently Asked Questions
Can you have von Willebrand disease with normal PT and aPTT?
Yes. PT is usually normal in von Willebrand disease because PT does not assess VWF, and aPTT can be normal when factor VIII remains above the level that prolongs the assay. A normal aPTT, often around 25-35 seconds depending on the laboratory, does not exclude mild type 1 or many type 2 cases. VWF antigen, platelet-dependent VWF activity, and factor VIII activity are the appropriate confirmatory tests when the bleeding history is compatible.
What level confirms von Willebrand disease?
A VWF antigen or platelet-dependent VWF activity result below 30 IU/dL supports a diagnosis of type 1 von Willebrand disease, even without a documented abnormal bleeding score. Values from 30-50 IU/dL can support diagnosis when a person has a convincing history of abnormal bleeding. Results must be interpreted using the laboratory's reference interval, because infection, pregnancy, stress, and estrogen can temporarily increase VWF. Repeat baseline testing is often needed.
What are the first signs of von Willebrand disease in women?
Heavy menstrual bleeding is often the first noticeable sign of von Willebrand disease in women and girls after menarche. Bleeding lasting more than 7 days, soaking a pad or tampon hourly for 2 consecutive hours, recurrent iron deficiency, and excessive bleeding after dental work strengthen suspicion. Ferritin below 15 micrograms/L indicates very low iron stores in most healthy adults, although symptoms can occur at higher values. Gynaecological causes of heavy periods still need assessment alongside VWD testing.
Does von Willebrand disease cause bruising?
Von Willebrand disease can cause easy bruising, but bruising alone is not enough to diagnose it. More suggestive bruising is spontaneous, repeatedly larger than 5 cm, or paired with nosebleeds, gum bleeding, heavy periods, or prolonged bleeding after surgery. A platelet count below 150 × 10^9/L suggests another or additional mechanism, although type 2B VWD can reduce platelet counts. A CBC and VWD-specific assays help separate these possibilities.
What test should I ask for if I suspect von Willebrand disease?
Ask a clinician whether VWF antigen, platelet-dependent VWF activity, and factor VIII activity are appropriate based on your bleeding history. A CBC, ferritin, PT/INR, and aPTT are useful companion tests, but normal PT and aPTT do not rule out VWD. If VWF activity is much lower than antigen, often with an activity-to-antigen ratio below about 0.7, specialised subtype testing may be needed. Testing is best performed when you are not acutely ill, immediately post-exercise, or actively bleeding.
Can von Willebrand disease get worse with age?
The inherited tendency in von Willebrand disease does not usually progress in the way a degenerative illness does, but bleeding burden can change with life events and medicines. Menstruation, childbirth, surgery, dental procedures, aspirin, anticoagulants, and age-related gastrointestinal conditions can make bleeding more apparent. VWF levels may rise with age in some people, yet a higher number does not always erase prior clinically significant bleeding. New bruising or bleeding beginning after age 50 should also prompt evaluation for acquired causes.
Get AI-Powered Blood Test Analysis Today
Join over 2 million users worldwide who trust Kantesti for instant, accurate lab test analysis. Upload your blood test results and receive comprehensive interpretation of 15,000+ biomarkers in seconds.
📚 Referenced Research Publications
Klein, T., Mitchell, S., & Weber, H. (2026). Kantesti Research Team. (2026). B Negative Blood Type, LDH Blood Test & Reticulocyte Count Guide. Figshare.. Kantesti AI Medical Research.
Klein, T., Mitchell, S., & Weber, H. (2026). Kantesti Research Team. (2026). Diarrhea After Fasting, Black Specks in Stool & GI Guide 2026. Figshare.. Kantesti AI Medical Research.
📖 External Medical References
⚕️ Medical Disclaimer
This article is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider for diagnosis and treatment decisions.
E-E-A-T Trust Signals
Experience
Physician-led clinical review of lab interpretation workflows.
Expertise
Laboratory medicine focus on how biomarkers behave in clinical context.
Authoritativeness
Written by Dr. Thomas Klein with review by Dr. Sarah Mitchell and Prof. Dr. Hans Weber.
Trustworthiness
Evidence-based interpretation with clear follow-up pathways to reduce alarm.